FdaApplication

ANDA 211293

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAMNEAL PHARMACEUTICALS LLC
application_typeANDA
approval_date2019-02-04

Products (5)

ProductActive ingredientStrengthDosage form
ESTRADIOLESTRADIOL0.075MG/24HRSYSTEM;TRANSDERMAL
ESTRADIOLESTRADIOL0.05MG/24HRSYSTEM;TRANSDERMAL
ESTRADIOLESTRADIOL0.025MG/24HRSYSTEM;TRANSDERMAL
ESTRADIOLESTRADIOL0.1MG/24HRSYSTEM;TRANSDERMAL
ESTRADIOLESTRADIOL0.0375MG/24HRSYSTEM;TRANSDERMAL

5 products